The Europe Cell therapy market is expected to reach US$ 3,610.7 million by 2027 from US$ 2,125.7 million in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019–2027. 

Market Introduction

The medical procedure known as cell therapy involves the introduction of viable, whole cells into a patient's body through techniques such as injection, implantation, or grafting. This therapeutic strategy relies on the substitution of dysfunctional cells with healthy, operational ones. Stem cells are indispensable for these advanced therapies due to their unique ability to develop into the precise cell types needed for the repair of damaged or defective tissues. Moreover, cell therapy is integral to the evolution of regenerative medicine. The projected growth of the Cell therapy market over the forecast period is likely to be driven by the increasing incidence of chronic illnesses, the expanding use of regenerative medicine approaches, and a growing count of authorized cell-based therapies.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00019052

Market Dynamics

Several factors are anticipated to stimulate the growth of the Cell therapy market in the years ahead, including the rising prevalence of chronic diseases, the increasing acceptance of regenerative medicine, and the growing number of approvals for cell-based treatments. Conversely, a potential obstacle to market growth during the forecast period is the substantial expense associated with cell therapy manufacturing, particularly in emerging economies.

The COVID-19 pandemic posed a significant challenge across the European landscape. The cell therapy instrument market experienced some initial contraction at the onset of the crisis due to factors such as supply chain disruptions and decreased demand resulting from widespread lockdowns across European nations. However, subsequent government support and initiatives led to a substantial increase in the demand for cell therapy.

Market Scope

The European Cell therapy market's scope is defined by therapy type, product, technology, application, end user, and country. Considering therapy types, the allogeneic segment held the largest market share in 2019, primarily attributed to the significant number of approved products available for clinical application. Nevertheless, the autologous segment is also expected to exhibit the highest CAGR within the market throughout the forecast period.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the Europe Cell therapy market report are the World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), Alliance for Regenerative Medicine, National Institutes of Health, Anthony Nolan Foundation, among others.

EUROPE CELL THERAPY MARKET SEGMENTATION

Europe Cell Therapy Market: By Therapy Type

  • Allogeneic
  • Autologous

Europe Cell Therapy Market:  By Product

  • Consumables
  • Equipment
  • Systems and Software

Europe Cell Therapy Market: By Technology

  • Viral Vector Technology
  • Genome Editing Technology
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technology

Europe Cell Therapy Market: By Application

  • Oncology
  • Cardiovascular
  • Orthopedic
  • Wound Management
  • Other Applications

 Europe Cell Therapy Market: By End User

  • Research Institutes
  • Hospitals
  • Others

 Europe Cell Therapy Market: By Country

  • Germany
  • France
  • Italy
  • UK
  • Spain

 Europe Cell Therapy Market: Company Profiles

  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc.
  • Mesoblast Limited
  • Smith & Nephew
  • Bristol-Myers Squibb Company
  • Cells for Cells

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications